Skip to main content
SpringerLink
Log in

Obesity and Metabolic Syndrome: Impact and Relationship with Menopausal Transition

  • Chapter
Frontiers in Gynecological Endocrinology

Part of the book series: ISGE Series ((ISGE))

Abstract

Western society predisposes to weight gain. We simply have too much food available. The real problem is the fact that human biology, especially in women, changes as people get to their 50s, when ageing and perimenopausal modifications take place little by little. Small changes in gonadal steroid production at the ovarian level together with some changes in the metabolic pathways and in the insulin sensitivity create the trigger for weight gain. Food intake and steroid modulation of the metabolic pathways are the basis for some of the relevant changes that facilitate the increase in body mass index and the occurrence of metabolic syndrome.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 64.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Flegal KM, Carroll MD, Ogden CL, Curtin LR (2010) Prevalence and trends in obesity among US adults, 1999–2008. JAMA 303(3):235–241

    Article  CAS  PubMed  Google Scholar 

  2. Genazzani AD, Vito G, Lanzoni C, Strucchi C, Mehmeti H, Ricchieri F, Mbusnum MN (2005) La Sindrome Metabolica menopausale. Giorn It Ost Gin 11/12:487–493

    Google Scholar 

  3. Ibrahim M (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11–18

    Article  PubMed  Google Scholar 

  4. Balkau B, Deanfield JE, Després JP, Bassand JP, Fox KA, Smith SC Jr, Barter P, Tan CE, Van Gaal L, Wittchen HU, Massien C, Haffner SM (2007) International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 116(17):1942–1951

    Article  PubMed Central  PubMed  Google Scholar 

  5. Carmina E (2013) Obesity, adipokines and metabolic syndrome in polycystic ovary syndrome. Front Horm Res 40:40–50

    Article  CAS  PubMed  Google Scholar 

  6. Davis SR, Castelo-Branco C, Chedraui P, Lumsden MA, Nappi RE, Shah D, Villaseca P, Writing Group of the International Menopause Society for World Menopause Day (2012) Understanding weight gain at menopause. Climacteric 15(5):419–429

    Article  CAS  PubMed  Google Scholar 

  7. Lovejoy JC, Champagne CM, De Longe L, Xie H, Smith SR (2008) Increased visceral fat and decreased energy expenditure during the menopausal transition. Int J Obes (Lond) 32(6):949–958

    Article  CAS  Google Scholar 

  8. Cagnacci A, Volpe A, Paoletti AM, Melis GB (1997) Regulation of the 24-hour rhythm of body temperature in menstrual cycles with spontaneous and gonadotropin-induced ovulation. Fertil Steril 68(3):421

    Article  CAS  PubMed  Google Scholar 

  9. Webb P (1986) 24-hour energy expenditure and the menstrual cycle. Am J Clin Nutr 44:14

    Google Scholar 

  10. Gambacciani M, Ciaponi M, Cappagli B, Benussi C, DeSimone L, Genazzani AR (1999) Climacteric modifications in body weight and fat tissue distribution. Climacteric 2(1):37–44

    Article  CAS  PubMed  Google Scholar 

  11. Roubenoff R, Hughes VA, Dallal EA et al (2000) The effect of gender and body composition method on the apparent decline in lean mass-adjusted resting metabolic rate with age. J Gerontol A Biol Sci Med Sci 55(12):M757–M760

    Article  CAS  PubMed  Google Scholar 

  12. Ravussin E, Lillioja S, Knowler WC et al (1988) Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 318(8):467–472

    Article  CAS  PubMed  Google Scholar 

  13. Veldhuis JD, Bowers CY (2003) Sex-steroid modulation of growth hormone (GH) secretory control: three-peptide ensemble regulation under dual feedback restraint by GH and IGF-I. Endocrine 22(1):25–40

    Article  CAS  PubMed  Google Scholar 

  14. Walenkamp JD, Wit JM (2006) Genetic disorders in the growth hormone-insulin-like growth factor-I axis. Horm Res 66(5):221–230

    Article  CAS  PubMed  Google Scholar 

  15. D’Eont M, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS (2005) Estrogen regulation of adiposity and fuel partitioning: evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem 280:35983–35991

    Article  Google Scholar 

  16. Messina G, Viggiano A, DeLuca V, Messina A, Chieffi S, Monda M (2013) Hormonal changes in menopause and Orexin-A action. Obstet Gynecol Int 2013:209812. doi:10.1155/2013/209812. Epub 2013 Jun 11.

  17. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M (2001) To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24:429–458

    Article  CAS  PubMed  Google Scholar 

  18. Kukkonen JP, Holmqvist T, Ammoun S, Akerman KEO (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol 283(6):C1567–C1591

    Article  CAS  Google Scholar 

  19. El-Sedeek M, Korish AA, Deef MM (2010) Plasma orexin- A levels in postmenopausal women: possible interaction with estrogen and correlation with cardiovascular risk status. BJOG 117(4):488–492

    Article  CAS  PubMed  Google Scholar 

  20. Genazzani AD, Ricchieri F, Lanzoni C (2010) Use of metformin in the treatment of polycystic ovary syndrome. Womens Health 6(4):577–593

    CAS  Google Scholar 

  21. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, Petraglia F, Genazzani AR (2000) Allopregnanolone concentrations and premenstrual syndrome. Eur J Endocrinol 142(3):269–273

    Article  CAS  PubMed  Google Scholar 

  22. Genazzani D, Chierchia E, Rattighieri E, Santagni S, Casarosa E, Luisi M, Genazzani AR (2010) Metformin administration restores allopregnanolone response to adrenocorticotropic hormone (ACTH) stimulation in overweight hyperinsulinemic patients with PCOS. Gynecol Endocrinol 26(9):684–689

    Article  CAS  PubMed  Google Scholar 

  23. Kerchner A, Lester W, Stuart SP, Dokras A (2009) Risk of depression and other mental health disorders in women with polycystic ovary syndrome: a longitudinal study. Fertil Steril 91:207–212

    Article  PubMed  Google Scholar 

  24. Genazzani AD, Strucchi C, Luisi M, Asarosa E, Lanzoni C, Baraldi E, Ricchieri F, Mehmeti H, Genazzani AR (2006) Metformin administration modulates neurosteroids secretion in non-obese amenorrheic patients with polycystic ovary syndrome. Gynecol Endocrinol 22(1):36–43

    Article  CAS  PubMed  Google Scholar 

  25. Genazzani AD, Lanzoni C, Ricchieri F, Jasonni VM (2008) Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol 24(3):139–144

    Article  CAS  PubMed  Google Scholar 

  26. Puurunen J, Piltonen T, Morin-Papunen L, Perheentupa A, Järvelä I, Ruokonen A, Tapanainen JS (2011) Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. J Clin Endocrinol Metab 96(6):1827–1834

    Article  CAS  PubMed  Google Scholar 

  27. Roussel M, Garnier S, Lemoine S, Gaubert I, Charbonnier L, Auneau G, Mauriège P (2009) Influence of a walking program on the metabolic risk profile of obese postmenopausal women. Menopause 16(3):566–575

    Article  PubMed  Google Scholar 

  28. Martins C, Kulseng B, King NA, Holst JJ, Blundell JE (2010) The effects of exercise-induced weight loss on appetite-related peptides and motivation to eat. J Clin Endocrinol Metab 95:1609–1616

    Article  CAS  PubMed  Google Scholar 

  29. Genazzani AR, Gambacciani M (2006) Effect of climacteric transition and hormone replacement therapy on body weight and body fat distribution. Gynecol Endocrinol 22(3):145–150

    Article  CAS  PubMed  Google Scholar 

  30. Tommaselli GA, DiCarlo C, Di Spiezio Sardo A, Bifulco CG, Cirillo D, Guida M, Papasso R, Nappi C (2006) Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 13:660–668

    Article  PubMed  Google Scholar 

  31. Di Carlo C, Tommaselli GA, Sammartino A, Bifulco G, Nasti A, Nappi C (2004) Serum leptin levels and body composition in postmenopausal women: effects of hormone therapy. Menopause 11:466–473

    Article  PubMed  Google Scholar 

  32. Meli R, Pacilio M, Mattace Raso G, Esposito E, Coppola A, Nasti A, Di Carlo C, Nappi C, Di Carlo C (2004) Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology 145:3115–3121

    Article  CAS  PubMed  Google Scholar 

  33. Sammel MD, Freeman EW, Liu Z, Lin H, Guo W (2009) Factors that influence entry into stages of the menopausal transition. Menopause 16(6):1218–1227

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Gynecological Endocrinology Center, University of Modena and Reggio Emilia, Modena, Italy

    Susanna Santagni, Erika Rattighieri, Elisa Chierchia, Giulia Despini, Alessia Prati & Alessandro D. Genazzani

Authors
  1. Susanna Santagni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erika Rattighieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elisa Chierchia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giulia Despini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessia Prati
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Alessandro D. Genazzani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandro D. Genazzani .

Editor information

Editors and Affiliations

  1. Department of Reproductive Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

    Bart C. J. M. Fauser

  2. International Society of Gynecological Endocrinology, Pisa, Italy

    Andrea R. Genazzani

Rights and permissions

Reprints and permissions

Copyright information

© 2015 International Society of Gynecological Endocrinology

About this chapter

Cite this chapter

Santagni, S., Rattighieri, E., Chierchia, E., Despini, G., Prati, A., Genazzani, A.D. (2015). Obesity and Metabolic Syndrome: Impact and Relationship with Menopausal Transition. In: Fauser, B.C.J.M., Genazzani, A.R. (eds) Frontiers in Gynecological Endocrinology. ISGE Series. Springer, Cham. https://doi.org/10.1007/978-3-319-09662-9_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09662-9_16

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09661-2

  • Online ISBN: 978-3-319-09662-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation